Cabrera Valerie Jorge, Hansson Joni, Kliger Alan S, Finkelstein Fredric O
Department of Medicine, Section of Nephrology, Yale University, New Haven, Connecticut; and.
Yale New Haven Health System-Performance Management, New Haven, Connecticut.
Clin J Am Soc Nephrol. 2017 Apr 3;12(4):687-693. doi: 10.2215/CJN.01650216. Epub 2017 Feb 1.
As kidney disease progresses, patients often experience a variety of symptoms. A challenge for the nephrologist is to help determine if these symptoms are related to advancing CKD or the effect of various comorbidities and/or medications prescribed. The clinician also must decide the timing of dialysis initiation. The initiation of dialysis can have a variable effect on quality of life measures and the alleviation of uremic signs and symptoms, such as anorexia, fatigue, cognitive impairment, depressive symptoms, pruritus, and sleep disturbances. Thus, the initiation of dialysis should be a shared decision-making process among the patient, the family and the nephrology team; information should be provided, in an ongoing dialogue, to patients and their families concerning the benefits, risks, and effect of dialysis therapies on their lives.
随着肾脏疾病的进展,患者常常会出现各种症状。肾病科医生面临的一项挑战是,要判断这些症状是与慢性肾脏病的进展有关,还是由各种合并症和/或所开药物的作用引起的。临床医生还必须决定开始透析的时机。开始透析对生活质量指标以及缓解尿毒症体征和症状(如厌食、疲劳、认知障碍、抑郁症状、瘙痒和睡眠障碍)可能会产生不同的影响。因此,透析的开始应该是患者、家属和肾病团队共同参与的决策过程;应通过持续对话,向患者及其家属提供有关透析治疗的益处、风险及其对生活影响的信息。